Intuitive Surgical falls 25% in 2026 ahead of Oct 20 Q3 report
The gist
Intuitive Surgical stock is down 25% year to date, with Q3 results due October 20.
Analysts expect $2.61 a share on $2.88b revenue, a da Vinci 5 test.
How it unfolded
- Aug 11, 2026Director Gary S. Guthart sold 10,000 shares at an average price of $400.00, a $4,000,000 transaction, and director Amy L. Ladd sold 72 shares at $393.10, both under pre-arranged Rule 10b5-1 trading plans.
- Oct 14, 2026Simply Wall St reported ISRG at US$422.06, up 53.3% over three years with a 47.5x P/E, and cited the FDA authorization of Johnson & Johnson's OTTAVA system as a fresh rival.
- Oct 16, 2026Analysts projected Q3 earnings of $2.61 per share on $2.88b in revenue; Zacks noted the stock was down 30% from early 2025 highs but up 30% from July lows, with a Zacks Rank #2 (Buy).